Fwd: FW: Directions for the road... to IPO - May 20

[Ryan Bethencourt]

Hi All, if anyone's interested in this workshop, we've got 4 free tickets from J&J. Feel free to register using the free pass code "RYANB". First come first served :)

From: "Viola, James [JRDUS Non-J&J]" <j...@ITS.JNJ.com>
Date: May 9, 2014 at 6:37 PM
To: Ryan Bethencourt <ryan.bet...@gmail.com>
Subject: FW: Directions for the road... to IPO - May 20

Ryan,

 

I have 4 free passes code  “RYANB”  if you know anyone who wants to go.  Your guys might be a little early.

 

 

Having trouble viewing this email? Click here

May 20, 2014 From the Trenches: Are you ready to IPO? Janssen Labs How to... Workshop   Program Overview 2013 was the year of the IPO for the biotech community with over 40 biotech companies going public. Biotech companies are continuing to be the toast of Wall Street in 2014 and as most soar above their IPO price, there appears to be no end in sight. But, even in this seemingly wide open window, not all life science companies should or could go public. If a potential IPO is on your radar screen, join us for an honest and transparent workshop about lessons learned and key insights from those who have recently traveled the road to IPO. The workshop will include detailed checklists from legal, accounting and communication professionals regarding the most important points to consider as you transition to a public company. Other questions answered include: Am I ready to go public? What are the most critical questions to ask on the road to IPO? How long will the window hold? What's life like after going public? The "How to... Workshop" series is dedicated to giving you the keys to a successful business, from creation to exit. As with all our events, the "How to... Workshop" is interactive and informal so bring your questions with you! Speakers Carin Canale-Theakston | President and Founder, Canale Communications Inc. Bryan Giraudo | Managing Director, Leerink John Orwin | President and Chief Executive Officer, Relypsa Inc. Richard Blake | Partner, Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP Agenda 11:00 AM | Registration, Lunch, and Networking 11:30 AM | Workshop 1:30 PM | Program Close Fees General Public | $35 Academic/Student Rate | $20 Location Genentech Hall Room N114 (GEN-N114) 600 16th Street San Francisco, CA 94158 Janssen Labs is part of Johnson & Johnson’s external R&D engine and provides a capital-efficient, resource-rich environment where emerging companies can transform the scientific discoveries of today into the breakthrough healthcare products of tomorrow. The 40,000 square foot flagship facility in San Diego at Janssen’s West Coast Research Center features core research labs hosting specialized capital equipment, shared administrative areas and individual bench, wet lab and office modules on a short term basis. Companies pay only for the space they need, with an option to quickly expand when they have the resources to do so. An operations team allows our companies to focus on the science and our business team provides access to education, experts and funding partners. Janssen Labs is a no strings attached, open innovation model, and the agreement for space does not grant Janssen any stake in the companies, nor will the companies have a guaranteed future affiliation with Janssen. For more information, visit www.janssenlabs.com. Johnson & Johnson Innovation, LLC focuses on accelerating early-stage innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and diagnostics and consumer companies of Johnson & Johnson. Johnson & Johnson Innovation includes local deal-making capabilities with the flexibility to adapt deal structures to match early-stage opportunities and establish novel collaborations that speed development of innovations to solve unmet needs in patients. For more information please visit: www.jnjinnovation.com. Bay Area Events May 20 | From the Trenches: Are you ready to IPO? Jun 4 | Meet with... Wellcome Trust Jun 10 | Janssen Labs@QB3 Open House     Accepting Applications Janssen Labs is looking for high-potential companies from diverse healthcare sectors. For information or to apply, please contact Kara Bortone or visit the Janssen Labs website. Meet Tim Lovenberg, Sr. Director of Neuroscience Drug Discovery for Janssen Labs. Tim is now a proud Scooter-commuter. Meet Jeff Calcagno, Principal of Venture Investments at JJDC. With the help of many patient friends and unsuspecting strangers, Jeff learned to speak five additional languages. Meet Beth Hill, Platform Innovation Lead at the California Innovation Center. Beth is a Star Student at Hamburger U. To find out more about J&J or other team members email: jnjinn...@its.jnj.com.     In the News Apr 28 | Janssen Labs Newsletter | Janssen Labs 10X Update - A Concentrated Dose of Innovation Feb 25 | Oxbridge Roundtable Business Bytes | Incubator vs Accelerator - What's the difference? Jan 17 | MedCity News | 3 biotech investment trends gleaned from JP Morgan conference       © Janssen Research & Development, LLC 2014. This event and the content of this program is the responsibility of the respective guest speakers and presenters only, and not of Janssen Research & Development, LLC.

 

Forward email This email was sent to mhol...@its.jnj.com by aga...@its.jnj.com |   Update Profile/Email Address | Instant removal with SafeUnsubscribe™ | Privacy Policy. Janssen Labs | 3210 Merryfield Row | San Diego | CA | 92121